Sinovac aims for 600 million dose capacity for COVID-19 vaccine

Chinese vaccine company Sinovac announced Monday that it is planning to complete a new facility to double its annual vaccine production capacity to 600 million doses by the end of the year, while also securing a US$500 million investment in a boost to its COVID-19 vaccine development efforts.